ARCHIVES

Massive Opposition Building To OMB Cuts; Legislative, Court Actions Predicted

This article is from The Cancer Letter archive.

Vol. 11 No. 08 | February 22, 1985

Download PDF Visit The Full Archive

Related Articles

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

Advisors approve NCI’s revised plan for $104-million proteomics research program.

July 8, 2005

Medicare Should Pay Routine Care For Patients in Trials: IOM.

January 7, 2000

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

In Brief: Diagnostic Imaging Cost Declines By Half as Percentage Of Health Cost In 10 Years

January 11, 1985

Rauscher Responds To Criticism

March 21, 1975